ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "surgery"

  • Abstract Number: 1556 • ACR Convergence 2023

    Abdominal Surgical Interventions Among Patients with Gastrointestinal Involvement of Behçet Syndrome

    Sinem Nihal Esatoglu1, Sabriye Guner1, Sevim Guler2, Gulen Hatemi1, Nuray Kepil3, Yusuf Ziya Erzin4, Aykut Ferhat Celik4 and Ibrahim Hatemi4, 1Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 2Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Istanbul, Turkey, 3Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Pathology, Istanbul, Turkey, 4Istanbul University-Cerrahpasa, Cerrahpasa Medical School, Department of Internal Medicine, Division of Gastroenterology, Istanbul, Turkey

    Background/Purpose: Gastrointestinal involvement of Behçet's syndrome (GIBS) may require surgery in up to one third of the patients. We aimed to investigate the clinical characteristics,…
  • Abstract Number: 1808 • ACR Convergence 2023

    Tobacco Smoking Reduces the Incidence and Delays the Progression of Knee Osteoarthritis: 10-year Retrospective Cohort Study Based on Korea National Health Insurance Service-Health Screening Database

    Junyong Park1, Minkook Son2, Sang Yeob Lee1, Wontae Chung1 and SungWon Lee1, 1Dong-A University Hospital, Busan, South Korea, 2Dong-A University, Busan, South Korea

    Background/Purpose: There are conflicting results about relationship between smoking and incidence of knee osteoarthritis (OA). The effect of smoking to preexisting knee OA has also…
  • Abstract Number: 2557 • ACR Convergence 2023

    Clinicopathologic Features of Patients with Giant Cell Arteritis and Thoracic Aorta Repair: A Single Center Experience over Two Decades

    Mahmut Kaymakci1, Nicholas Boire1, Melanie Bois1, Mohanad Elfishawi1, Hannah Langenfeld2, Andrew Hanson2, Cynthia Crowson1, Matthew Koster1, Cornelia M. Weyand3 and Kenneth Warrington1, 1Mayo Clinic, Rochester, MN, 2Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, 3Mayo Clinic School of Medicine and Stanford University, Rochester, MN

    Background/Purpose: Patients with giant cell arteritis (GCA) are at increased risk of thoracic aortic aneurysm and dissection. This late complication of the disease is presumed…
  • Abstract Number: 2558 • ACR Convergence 2023

    Aortic Aneurysms in a Multicenter Cohort of 196 Patients with Aortitis Related to Giant Cell Arteritis Treated with Tocilizumab

    Fernando López1, Javier Loricera2, Adrián Martín-Gutiérrez3, Carmen Secada3, Santos Castañeda4, Clara Moriano Morales5, Javier Narvaez6, Vicente Aldasoro7, Olga Maiz8, Rafael Benito Melero-Gonzalez9, PALOMA VELA10, Susana Romero Yuste11, Eugenio De Miguel12, Eva Galindez-Agirregoikoa13, Jesús Carlos Fernández López14, Ivan Ferraz Amaro15, Julio Sánchez-Martín3, Jose L. Callejas16, Patricia Moya Albarado17 and Ricardo Blanco18, 1Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla, Santander, Spain, 3Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, 4Hospital Universitario de la Princesa, Madrid, Spain, 5Rheumatology, Hospital Universitario de León, León, Spain, 6Hospital Universitario de Bellvitge, Barcelona, Spain, 7Hospital Universitario de Navarra, Pamplona, Spain, 8Hospital Universitario de Donostia. San Sebastián, Spain., Donosti, Spain, 9CHU Vigo, O Carballino, Spain, 10Rheumatology, Hospital General Universitario Alicante, Alicante, Spain, 11Complexo Hospitalario Universitario, Pontevedra, Spain, 12Hospital Universitario La Paz, Madrid, Spain, 13Basurto University Hospital, Bilbao, Spain, 14Rheumatology department, Complexo Hospitalario Universitario A Coruña (CHUAC). Instituto de Investigación Biomédica A Coruña (INIBIC), A Coruña, Spain, 15Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, 16Unit of Systemic Autoimmune Diseases, Hospital San Cecilio, Granada, Spain, 17Hospital Universitario de Sant Pau, Barcelona, Spain, 18Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Aortic aneurysms is a serious complication that can occur in patients with giant cell arteritis (GCA) (1-2). Tocilizumab (TCZ) is approved for GCA. Nevertheless,…
  • Abstract Number: 054 • 2023 Pediatric Rheumatology Symposium

    Craniofacial Localized Scleroderma: A Single Center Retrospective Cohort

    Leigh Stubbs, Ammar Hashemi, Raegan Hunt and Renata Maricevich, Baylor College of Medicine, Houston, TX

    Background/Purpose: Craniofacial localized scleroderma (LS) can lead to disfigurement and severe extracutaneous manifestations (ECMs). There is an ongoing need to standardize multidisciplinary evaluation and care.…
  • Abstract Number: 0502 • ACR Convergence 2022

    The Effect of Osteoporosis on Developing Vertebral Compression Fracture After Single-level Posterior Lumbar Fusion Surgery: A Large Healthcare Claims Database Study

    Vartika Kesarwani1, Sean Esmende2, Regina Kostyun2, Matthew Solomito2, Heeren Makanji2, John Magaldi2 and Mandeep Kumar2, 1University of Connecticut, Farmington, CT, 2Bone and Joint Institute, Hartford Hospital, Hartford, CT

    Background/Purpose: Vertebral compression fracture (VCF) is a significant osteoporosis-related complication (ORC) associated with instrumented spinal fusion. Various studies have assessed the development of VCF in…
  • Abstract Number: 0835 • ACR Convergence 2022

    Temporal Trends in Prosthetic Joint Infection

    Anne Bass1, Yi Zhang,2, Peter Sculco2, huong do2, Kayla Glaser2, alberto Carli2, Mark Figgie2 and Susan Goodman2, 1Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 2Hospital for Special Surgery, New York, NY

    Background/Purpose: Prosthetic joint infection (PJI) is a dreaded complication of total knee replacement (TKR) that usually requires removal of the prosthesis, treatment with antibiotics and…
  • Abstract Number: 0837 • ACR Convergence 2022

    Providers’ Adoption of 2017 Guidelines on DMARD Use Perioperatively for Elective Total Hip and Knee Arthroplasty at a Single Academic Center

    Chris Ching1, Erica Mulcaire-Jones2, Andrew Shaffer1, Jeremy Gililland1, Michael Battistone3 and Dorota Lebiedz-Odrobina1, 1University of Utah, Salt Lake City, UT, 2Intermountain Healthcare, Salt Lake City, UT, 3Salt Lake City VA, Salt Lake City, UT

    Background/Purpose: Rate of prosthetic joint infection (PJI) after total joint arthroplasty (TJA) is higher in patients with rheumatic conditions than in patients with OA. Our…
  • Abstract Number: 0848 • ACR Convergence 2022

    Postoperative Flares and Peri-arthroscopic Management of Immunosuppressive Medications in Patients with Rheumatic Disease

    Kinjal Vasvada1, Dhruv Shankar1, Amanda Avila1, Charles Lin1, David Marulanda2, Laith Jazrawi1 and Jonathan Samuels3, 1NYU Langone Health, New York, NY, 2NYU Langone Health, Philadelphia, 3NYU Langone, Rye Brook, NY

    Background/Purpose: To determine the rate and characteristics of postoperative flares in rheumatic disease patients undergoing arthroscopic surgery, and the role of perioperative immunosuppression (IS) management…
  • Abstract Number: 1289 • ACR Convergence 2022

    Evaluating Peri–operative Preferences of Bariatric Surgeons in the Management of Immunosuppressive Therapy During Bariatric Surgery

    Suguni Aushadhi Loku Galappaththy1 and Nicole Fearing2, 1University of Missouri Kansas City, Kansas City, MO, 2HCA Menorah Medical Center, Overland Park, KS

    Background/Purpose: As the number of bariatric procedures increases, surgeons will encounter more patients on long-term immunosuppressive medications that may increase post-operative complications. Currently, there are…
  • Abstract Number: 0083 • ACR Convergence 2021

    Cardiac Valve Surgery Outcomes in the Antiphospholipid Syndrome

    Tali Eviatar1, Stanley Niznik2, Nancy Agmon-Levin2 and Daphna Paran3, 1Tel Aviv Sourasky Medical Center, Givataim, Israel, 2Sheba Medical Center, Ramat Gan, Israel, 3Tel Aviv Sourasky Medical Center-Ichilov Hospital, Even Yehuda, Israel

    Background/Purpose: Cardiac valve involvement in the APS is prevalent, necessitating valve surgery in about 5% of the patients. Data regarding valve surgery outcomes in APS…
  • Abstract Number: 0663 • ACR Convergence 2021

    Disappearing Digits: A National Retrospective Matched Cohort Study Examining the Risk of Lower Extremity Amputation in Gout

    Quint Soto1, Alison Petro1, Bryant England1, Harlan Sayles1, Lindsay Helget1, Punyasha Roul1, Tuhina Neogi2, James O'Dell1, Brian LaMoreaux3 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2Boston University School of Medicine, Boston, MA, 3Horizon Therapeutics plc, Deerfield, IL

    Background/Purpose: Gout is associated with a number of comorbidities such as diabetes that are known risk factors for peripheral vascular disease. These comorbidities along with…
  • Abstract Number: 1881 • ACR Convergence 2021

    Surgical Outcomes After Operative Procedures in Patients with Behcet’s Disease

    Youjin Jung and Eun bong Lee, Seoul National University Hospital, Seoul, Republic of Korea

    Background/Purpose: Behcet's disease (BD) is characterized by hyper-inflammatory response to trauma, which is called the pathergy phenomenon. Therefore, there are concerns about post-operative complications when…
  • Abstract Number: 0330 • ACR Convergence 2020

    Musculoskeletal Surgery in Psoriatic Arthritis: Prevalence and Risk Factors

    Timothy Kwok1, Mitchell Sutton2, Daniel Pereira2, Vinod Chandran3 and Dafna Gladman3, 1University of Toronto, Toronto, ON, Canada, 2Centre for Prognosis Studies in the Rheumatic Diseases, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, Canada, 3Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose: Despite optimal medical therapy, joint space disease and skeletal damage persists in a subset of patients with PsA, many of whom requiring musculoskeletal (MSK)…
  • Abstract Number: 0480 • ACR Convergence 2020

    Impact of Targeting Remission or Low Disease Activity on 10-year Severity in Rheumatoid Arthritis : Data from ESPOIR Cohort

    Julia Dupont1, Gregory Guernec2, Yannick Degboé3, Frédéric Lioté4, Olivier Vittecoq5, Arnaud Constantin6 and Adeline Ruyssen Witrand7, 1University Hospital of Thoulouse, Toulouse, 2Inserm UMR 1027, TOULOUSE CEDEX 9, France, 3University Hospital of Toulouse, Toulouse, 4AP-HP, Paris, France, 5University Hospital of Rouen, Rouen, France, 6Rheumatology Department, Toulouse University Hospital, Toulouse, France, 7Rheumatology center, University Hospital of Toulouse, Inserm 1027, University Paul Sabatier, Toulouse, France, Toulouse, France

    Background/Purpose: The aim of rheumatoid arthritis (RA) treatment is to target remission or at least low disease activity (LDA). We previously showed that SDAI remission…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology